PDK1 and ovarian carcinoma: We also elucidated the mechanisms by which COL11A1 promotes cancer cell sensitivity to anticancer drugs and we observed that, in ovarian cancer cells, chemoresistance developed via activation of the Akt/c/EBPβ pathway in concert with attenuated PDK1 ubiquitination and degradation22.